A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- A $750 million effort to revolutionize cancer care in N.J. opens next month.
- New study raises alarm over Alzheimer’s blood tests.
- Elevated Serum cAMP Findings May Allow Asthma Diagnosis by Blood Test.
- Tariffs could have deep impacts on costs for prescription drugs: What to know.
- New NJACTS Publication
Categories
- Community (2,215)
- Covid (985)
- CTO Events (6)
- News (2,826)
- Pilots (21)